Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(898/week)
    • Manufacturing(434/week)
    • Technology(914/week)
    • Energy(322/week)
    • Other Manufacturing(289/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

European Hematology Association (EHA)

Nov 25, 2024
EHA Highlights Commitment to Innovation and Collaboration at ASH Annual Meeting
Jul 15, 2024
EHA: Bridging Breakthroughs in Hematology
Aug 28, 2020
European Hematology Association launching new European Immunotherapy Net website
Jun 13, 2020
EHA25Virtual: A Paradigm Shift for the Treatment of Newly Diagnosed Older Acute Myeloid Leukemia Patients
Jun 13, 2020
EHA25Virtual: Adult Patients With Sickle Cell Disease May Be at Increased Risk of Adverse Outcomes From COVID-19
Jun 13, 2020
EHA25Virtual: Study of Subcutaneous Daratumumab Shows Improved Clinical Outcomes in the Treatment of Patients with Amyloidosis
Jun 12, 2020
EHA25Virtual: Advances in Treatment of High Risk Chronic Lymphocytic Leukemia
Jun 12, 2020
EHA25Virtual: Gut Microbiome Disturbance by Antibiotic Treatment Early in Life is Sufficient to Induce Leukemia in Predisposed Mice
Jun 12, 2020
EHA25Virtual: Promising Treatment Results with Imetelstat, a Novel Telomerase Inhibitor, in Patients with Lower Risk Myelodysplastic Syndromes
Jun 12, 2020
EHA25Virtual: Pegcetacoplan, a Novel C3 Complement Inhibitor - Beginning of a New Era in the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)
Jun 12, 2020
EHA25Virtual: A Safe and Strikingly Effective Biologic Therapy for the World's Second Most Common Hereditary Bleeding Disorder
Jun 12, 2020
EHA25Virtual: Combined Irradiation and Chemotherapy Better Prepares Children for Stem Cell Transplantation than Chemotherapy Alone
Jun 12, 2020
EHA25Virtual: A New Paradigm in Relapsed Refractory Hodgkin Lymphoma
Jun 12, 2020
EHA25Virtual: Ruxolitinib, the First Proven Drug for Treating Steroid-refractory Acute GVHD
Jun 12, 2020
EHA25Virtual: PET-guided Therapy Allows Omission of Radiotherapy in Early-stage Unfavorable Hodgkin Lymphoma
Jun 09, 2020
25th Congress of the European Hematology Association (EHA): The First Ever Virtual Edition

Latest News

May 30, 2025

Faraday Future Secures Binding Deposit for 600 FX Super One MPV from New PBB Auto, and is Also Exploring a...

May 30, 2025

Tamboran announces successful closing of First Tranche of PIPE

May 30, 2025

Northrop Grumman Invests $50 Million in Firefly Aerospace to Advance Eclipseâ„¢ Medium Launch Vehicle

May 30, 2025

Patria to begin assembly of ASCOD Infantry Fighting Vehicles in Latvia

May 30, 2025

U.S. Space & Rocket Center holds Blue Origin flight launch party

May 30, 2025

Cellares and Mitsui Fudosan Announce the First IDMO Smart Factory for Commercial-Scale Cell Therapy...

May 30, 2025

Laser Photonics Received NASDAQ Notice of Delisting for Failure to Satisfy a Continued Listing Rule or...

May 30, 2025

JETOUR Achieves No.1 Sales Among Chinese Brands in Middle East from January to April 2025

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Seabed Security (30 September - 01 October 2025 in...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia